AUSTIN, Texas--(BUSINESS WIRE)--Receptor Logic, Ltd. has announced a partnership with sanofi pasteur, the vaccines division of sanofi-aventis Group, to develop T Cell Receptor Mimics (TCRm™) for the validation and testing of sanofi pasteur vaccines. Under a collaborative research and exclusive license agreement, Receptor Logic will create custom TCRm in support of sanofi pasteur’s vaccine programs. Receptor Logic is funded and managed by life sciences venture firm, Emergent Technologies, Inc. (ETI).
